Prevalence and antimicrobial susceptibility profile of Acinetobacter Species, among blood culture samples received at Makerere University College of Health Science (MakCHS) Clinical Microbiology Laboratory between March and August 2021.
View/ Open
Date
2021-12Author
Isabirye, Robert
Turyatunga, Derrick
Mwondha, Ronald
Sekituku, Morris
Metadata
Show full item recordAbstract
Acinetobacter spp. are glucose-non-fermentative, non-motile, non-fastidious, catalase-positive,
oxidative-negative, aerobic gram-negative cocco-bacilli (Lin & Lan, 2014) present in the
environment especially water and soil but can be isolated from many sources such as skin,
wounds, sewage and hospital environments. It is one of the most successful pathogens
responsible for hospital-acquired nosocomial infections in the modern healthcare system (Chang,
et al., 2017).
Methodology
The study was a cross sectional study done retrospectively to determine the prevalence and
antibiotic susceptibility profile of Acinetobacter isolated from blood cultures at the Makerere
University College of Health Sciences Clinical Microbiology Laboratory between March 2021
and August 2021. The blood culture records were reviewed for Acinetobacter spp and those without proper
identification of organisms were re-identified, then a few selected stored samples were removed
from the repository and re-identified with gram test and biochemical tests. Then the prevalence
of Acinetobacter, susceptibility to different antibiotics was analyzed and recorded.
Results
A total of 3021 blood culture samples were received from patients in medical wards, surgery
wards, intensive care units, samples from pediatric wards and patients on cancer therapy from
UCI between March 2021 and August 2021, 2985 samples were processed, 36 samples were
rejected, and out 2985 sample processed 271 were tested positive for various pathogens and of
those, only 12 tested positive for Acinetobacter. The prevalence of Acinetobacter therefore was
12/271 = 4.43%. The susceptibility results were as follows; of the 10 samples set for Cephalosporins, 4(40%)
were sensitive, while 5(50%) were resistant and only one was intermediate. Of the 12 samples
set for Carbapenems, 6(50%) were sensitive, while 4(33.3%) were resistant and 2 were
intermediate. Of the 12 samples set for quinolones, 7(58.3%) were sensitive, 4(33.3%) were
resistant while 1 was intermediate. Of the 7 samples set for sulfonamides, 4(57.1%) were
sensitive, while 3(42.9%) were resistant. Of the 9 samples sets for penicillins, 4(44.4%) were
sensitive, 4(44.4%) were resistant while 1 was intermediate.
Conclusion
The Acinetobacter organisms identified from blood culture samples with a total of 12 isolates
from March to August 2021 gave us a prevalence of 4.43%. The highest prevalence was
observed in adults (80%) while children (8.3%) had the lowest prevalence.